AI based longitudinal changes in substantia nigra contrast and volume on neuromelanin MRI and its relation to clinical markers in a multi-site Parkinson's disease (PD) study

被引：0
|
作者：
Ingalhalikar, M.
Pham, H.
Bracoud, L.
Hutchison, M. H.
Evans, K.
Dam, T.
Nguyen, K. N.
Conklin, C. C.
Suhy, J. S.
Scott, D. S.
机构：
来源：
MOVEMENT DISORDERS | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1066
引用
收藏
页码：S494 / S495
页数：2
相关论文
共 23 条
  • [1] Characterization of neuromelanin MRI as a potential Parkinson's Disease biomarker in a multi-site longitudinal study
    Ingalhalikar, M.
    Pham, H.
    Bracoud, L.
    Hutchison, R. M.
    Evans, K.
    Dam, T.
    Sampat, M.
    Schaerer, J.
    Suhy, C. Conklin J.
    Scott, D.
    MOVEMENT DISORDERS, 2022, 37 : S78 - S80
  • [2] Optimization of a neuromelanin MRI protocol for use in a longitudinal study of substantia nigra depigmentation in early Parkinson's Disease (the InsIght-PD study)
    Hayat, T.
    Pszczolkowski, S.
    Xing, Y.
    Tench, C.
    Morgan, P.
    Evans, J.
    Auer, D.
    MOVEMENT DISORDERS, 2022, 37 : S74 - S75
  • [3] Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study
    Safai, Apoorva
    Prasad, Shweta
    Chougule, Tanay
    Saini, Jitender
    Pal, Pramod K.
    Ingalhalikar, Madhura
    HUMAN BRAIN MAPPING, 2020, 41 (05) : 1323 - 1333
  • [4] Spatiotemporal Changes in Substantia Nigra Neuromelanin Content from Prodromal to Clinical Parkinson's Disease
    Biondetti, E.
    Gaurav, R.
    Yahia-Cherif, L.
    Mangone, G.
    Pyatigorskaya, N.
    Valabregue, R.
    Ewenczyk, C.
    Hutchison, M.
    Francois, C.
    Corvol, J. -C.
    Vidailhet, M.
    Lehericy, S.
    MOVEMENT DISORDERS, 2020, 35 : S236 - S237
  • [5] Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study
    Ofori, Edward
    Pasternak, Ofer
    Planetta, Peggy J.
    Burciu, Roxana
    Snyder, Amy
    Febo, Marcelo
    Golde, Todd E.
    Okun, Michael S.
    Vaillancourt, David E.
    NEUROBIOLOGY OF AGING, 2015, 36 (02) : 1097 - 1104
  • [6] Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Longitudinal Study
    Gaurav, R.
    Yahia-Cherif, L.
    Mangone, G.
    Pyatigorskaya, N.
    Valabregue, R.
    Ewenczyk, C.
    Hutchison, M.
    Corvol, J.
    Vidailhet, M.
    Lehericy, S.
    MOVEMENT DISORDERS, 2019, 34 : S789 - S790
  • [7] Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
    Daniela Berg
    Christiane Siefker
    Georg Becker
    Journal of Neurology, 2001, 248 : 684 - 689
  • [8] Evaluating Volume Changes in the Substantia Nigra Pars Compacta (SNc) in Parkinson's Disease (PD) in a Study-Specific Magnetic Resonance Imaging (MRI) Template
    Biondetti, E.
    Gaurav, R.
    Yahia-Cherif, L.
    Mangone, G.
    Pyatigorskaya, N.
    Valabregue, R.
    Ewenczyk, C.
    Hutchison, M.
    Corvol, J. C.
    Vidailhet, M. J.
    Lehericy, S.
    MOVEMENT DISORDERS, 2019, 34 : S772 - S773
  • [9] In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts
    Hwang, Kristy S.
    Langley, Jason
    Tripathi, Richa
    Hu, Xiaoping P.
    Huddleston, Daniel E.
    PLOS ONE, 2023, 18 (04):
  • [10] Centralizing brain tissue donation for a large multi-site Parkinson's disease (PD) study
    Heathers, L.
    Foroud, T.
    Antonopoulos, G.
    Mantravadi, K.
    Lenfert, B.
    MOVEMENT DISORDERS, 2024, 39 : S318 - S318
123